Skip to content
Triangle logo TriangleGet started
← Full study record

NCT00556452 · OUTCOME

Five Year Overall Survival for All Cases

Study of Stem Cell Transplantation for Hematologic Malignancies Using Clofarabine and Busulfan Regimen · Source last updated 2017-12-05

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

Measure
COUNT_OF_PARTICIPANTS
Unit
Participants
Interval / dispersion
Not reported
Time frame
five years

What was measured

The number of patients alive at 5 years

Groups in this outcome

Clo/BU4

Study will start at the 2nd dose level of three Clofarabine levels, in combination with Busulfan. The Clofarabine level that each subsequent patient is treated at is determined by a method using continual reassessment. After pre-conditioning, subjects will receive a peripheral blood stem cell transplant. Total Lymphoid Irradiation : Total Lymphoid Irradiation (TLI) of 4 Gy, if cord blood transplant Clofarabine/Busulfan x 4 : Clofarabine IV (dose levels) * 1st dose level: 20 mg/m2/day x 5 days * 2nd dose level: 30 mg/m2/day x 5 days * 3rd dose level: 40 mg/m2/day x 5 days Busulfan IV 3.2 mg/kg daily x 4 days Peripheral blood stem cell transplant : Peripheral blood stem cell transplant, after pre-conditioning drug treatment

Group identifiers and denominators belong to this outcome only. They may differ in another outcome or in safety reporting.

Analysis denominator · Participants

GroupSource count
Clo/BU446

Reported measurements

Source class 1
Values in Participants · Interval/dispersion: Not reported
GroupValueSpreadLowerUpperComment
Clo/BU46Not reportedNot reportedNot reportedNot reported
Complete source fields
classes
  1. categories
    1. measurements
      1. group Id
        OG000
        value
        6
denoms
  1. counts
    1. group Id
      OG000
      value
      46
    units
    Participants
description
The number of patients alive at 5 years
groups
  1. description
    Study will start at the 2nd dose level of three Clofarabine levels, in combination with Busulfan. The Clofarabine level that each subsequent patient is treated at is determined by a method using continual reassessment. After pre-conditioning, subjects will receive a peripheral blood stem cell transplant. Total Lymphoid Irradiation : Total Lymphoid Irradiation (TLI) of 4 Gy, if cord blood transplant Clofarabine/Busulfan x 4 : Clofarabine IV (dose levels) * 1st dose level: 20 mg/m2/day x 5 days * 2nd dose level: 30 mg/m2/day x 5 days * 3rd dose level: 40 mg/m2/day x 5 days Busulfan IV 3.2 mg/kg daily x 4 days Peripheral blood stem cell transplant : Peripheral blood stem cell transplant, after pre-conditioning drug treatment
    id
    OG000
    title
    Clo/BU4
param Type
COUNT_OF_PARTICIPANTS
reporting Status
POSTED
time Frame
five years
title
Five Year Overall Survival for All Cases
type
SECONDARY
unit Of Measure
Participants

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice